1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. GRITSTONE BIO INC
Gritstone Bio Inc XNAS: GRTSQ

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Gritstone Bio Inc is on 01 Jul 2025 for the purpose of Gritstone Bio Inc First Quarter Earnings Result for 2025 See details


Insider Trading disclosures for Gritstone Bio Inc

The latest disclosure was made by Stephen W. Webster in Gritstone Bio Inc where a trade of 7,379 Stock Option (Right to Buy) done was reported to US exchanges on April 4, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Stephen W. Webster Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 7,379 0 - - Stock Option (Right to Buy)
Stephen W. Webster Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 25,000 0 (0%) 0% 0 Common Stock
Stephen W. Webster Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 103,600 0 - - Stock Option (Right to Buy)
Naiyer A. Rizvi Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 937 0 - - Stock Option (Right to Buy)
Naiyer A. Rizvi Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 51,800 0 - - Stock Option (Right to Buy)
Naiyer A. Rizvi Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 51,800 0 - - Stock Option (Right to Buy)
Naiyer A. Rizvi Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 19,000 0 - - Stock Option (Right to Buy)
Naiyer A. Rizvi Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 38,000 0 - - Stock Option (Right to Buy)
Naiyer A. Rizvi Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 7,500 0 - - Stock Option (Right to Buy)
Naiyer A. Rizvi Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 4,347 0 - - Stock Option (Right to Buy)
Naiyer A. Rizvi Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 10,000 0 - - Stock Option (Right to Buy)
Shefali Agarwal Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 51,800 0 - - Stock Option (Right to Buy)
Shefali Agarwal Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 51,800 0 - - Stock Option (Right to Buy)
Shefali Agarwal Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 38,000 0 - - Stock Option (Right to Buy)
Shefali Agarwal Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 937 0 - - Stock Option (Right to Buy)
Shefali Agarwal Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 19,000 0 - - Stock Option (Right to Buy)
Vassiliki Economides EVP, CHIEF FINANCIAL OFFICER Other type of transaction at price $ 0.00 per share. 04 Apr 2025 250,437 0 (0%) 0% 0 Common Stock
Vassiliki Economides EVP, CHIEF FINANCIAL OFFICER Other type of transaction at price $ 0.00 per share. 04 Apr 2025 138,000 0 - - Stock Option (Right to Buy)
Vassiliki Economides EVP, CHIEF FINANCIAL OFFICER Other type of transaction at price $ 0.00 per share. 04 Apr 2025 215,000 0 - - Stock Option (Right to Buy)
Vassiliki Economides EVP, CHIEF FINANCIAL OFFICER Other type of transaction at price $ 0.00 per share. 04 Apr 2025 215,000 0 - - Stock Option (Right to Buy)
James Cho SVP, CHIEF ACCOUNTING OFFICER Other type of transaction at price $ 0.00 per share. 04 Apr 2025 40,000 0 - - Stock Option (Right to Buy)
James Cho SVP, CHIEF ACCOUNTING OFFICER Other type of transaction at price $ 0.00 per share. 04 Apr 2025 155,123 0 (0%) 0% 0 Common Stock
James Cho SVP, CHIEF ACCOUNTING OFFICER Other type of transaction at price $ 0.00 per share. 04 Apr 2025 109,000 0 - - Stock Option (Right to Buy)
James Cho SVP, CHIEF ACCOUNTING OFFICER Other type of transaction at price $ 0.00 per share. 04 Apr 2025 65,400 0 - - Stock Option (Right to Buy)
James Cho SVP, CHIEF ACCOUNTING OFFICER Other type of transaction at price $ 0.00 per share. 04 Apr 2025 26,300 0 - - Stock Option (Right to Buy)
James Cho SVP, CHIEF ACCOUNTING OFFICER Other type of transaction at price $ 0.00 per share. 04 Apr 2025 25,000 0 - - Stock Option (Right to Buy)
Clare Fisher Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 8,693 0 - - Stcok Option (right to buy)
Clare Fisher Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 38,000 0 - - Stock Option (Right to Buy)
Clare Fisher Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 51,800 0 - - Stock Option (Right to Buy)
Clare Fisher Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 51,800 0 - - Stock Option (Right to Buy)
Lawrence Corey Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 51,800 0 - - Stock Option (Right to Buy)
Lawrence Corey Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 38,000 0 - - Stcok Option (right to buy)
Lawrence Corey Director Other type of transaction at price $ 0.00 per share. 04 Apr 2025 51,800 0 - - Stock Option (Right to Buy)
Economides Vassiliki EVP, CHIEF FINANCIAL OFFICER Sale of securities on an exchange or to another person at price $ 0.02 per share. 18 Dec 2024 12,000 250,437 (0%) 0% 0.0 180 Common Stock
Andrew R. Allen Director, PRESIDENT AND CEO Gift of securities by or to the insider at price $ 0.00 per share. 24 Jun 2024 325,000 985,360 (2%) 0% 0 Common Stock
Andrew R. Allen Director, PRESIDENT AND CEO Gift of securities by or to the insider at price $ 0.00 per share. 24 Jun 2024 325,000 1,124,275 (3%) 0% 0 Common Stock
Stephen W. Webster Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 7,379 7,379 - - Stock Option (Right to Buy)
Naiyer A. Rizvi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 51,800 51,800 - - Stock Option (Right to Buy)
Shefali Agarwal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 51,800 51,800 - - Stock Option (Right to Buy)
Clare Fisher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 51,800 51,800 - - Stock Option (Right to Buy)
Lawrence Corey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 51,800 51,800 - - Stock Option (Right to Buy)
Andrew R. Allen Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 615,000 615,000 - - Stock Option (Right to Buy)
Andrew R. Allen Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 0.75 per share. 15 May 2024 24,263 985,360 (2%) 0% 0.7 18,156 Common Stock
Andrew R. Allen Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 47,873 1,009,623 (2%) 0% 0 Common Stock
Erin Jones EVP, CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 27,128 373,042 (1%) 0% 0 Common Stock
Erin Jones EVP, CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 235,000 235,000 - - Stock Option (Right to Buy)
Erin Jones EVP, CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 0.75 per share. 15 May 2024 13,749 359,293 (1%) 0% 0.7 10,288 Common Stock
Matthew J. Hawryluk EVP, CHIEF BUSINESS OFFICER Sale of securities on an exchange or to another person at price $ 0.75 per share. 15 May 2024 9,259 313,931 (0%) 0% 0.7 6,929 Common Stock
Matthew J. Hawryluk EVP, CHIEF BUSINESS OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 180,000 180,000 - - Stock Option (Right to Buy)
Matthew J. Hawryluk EVP, CHIEF BUSINESS OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 19,149 323,190 (0%) 0% 0 Common Stock
Karin Jooss SEE REMARKS Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 27,128 697,275 (1%) 0% 0 Common Stock
Karin Jooss SEE REMARKS Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 235,000 235,000 - - Stock Option (Right to Buy)
Karin Jooss SEE REMARKS Sale of securities on an exchange or to another person at price $ 0.75 per share. 15 May 2024 13,749 683,526 (1%) 0% 0.7 10,288 Common Stock
Vassiliki Economides EVP, CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 215,000 215,000 - - Stock Option (Right to Buy)
Vassiliki Economides EVP, CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 27,128 276,186 (0%) 0% 0 Common Stock
Vassiliki Economides EVP, CHIEF FINANCIAL OFFICER Sale of securities on an exchange or to another person at price $ 0.75 per share. 15 May 2024 13,749 262,437 (0%) 0% 0.7 10,288 Common Stock
James Cho SVP, CHIEF ACCOUNTING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2024 10,800 155,123 (0%) 0% 0 Common Stock
James Cho SVP, CHIEF ACCOUNTING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2024 65,400 65,400 - - Stock Option (Right to Buy)
Stephen W. Webster Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2024 103,600 103,600 - - Stock Option (Right to Buy)
Erin Jones EVP, CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 235,000 235,000 - - Stock Option (Right to Buy)
Matthew J. Hawryluk EVP, CHIEF BUSINESS OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 35,000 286,880 (0%) 0% 0 Common Stock
Jooss Karin SEE REMARKS Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 40,000 648,851 (1%) 0% 0 Common Stock
Allen R. Andrew Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 615,000 615,000 - - Stock Option (Right to Buy)
Andrew R. Allen Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 105,000 899,345 (2%) 0% 0 Common Stock
Vassiliki Economides EVP, CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 215,000 215,000 - - Stock Option (Right to Buy)
Vassiliki Economides EVP, CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 35,000 227,762 (0%) 0% 0 Common Stock
J. Matthew Hawryluk EVP, CHIEF BUSINESS OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 180,000 180,000 - - Stock Option (Right to Buy)
Cho James SVP, CHIEF ACCOUNTING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 109,000 109,000 - - Stock Option (Right to Buy)
Jones Erin EVP, CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 40,000 324,618 (0%) 0% 0 Common Stock
James Cho SVP, CHIEF ACCOUNTING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 18,000 138,644 (0%) 0% 0 Common Stock
Jooss Karin SEE REMARKS Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 235,000 235,000 - - Stock Option (Right to Buy)
Steve E. Krognes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 51,800 51,800 - - Stock Option (Right to Buy)
Naiyer Rizvi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 51,800 51,800 - - Stock Option (Right to Buy)
Shefali Agarwal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 51,800 51,800 - - Stock Option (Right to Buy)
Clare Fisher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 51,800 51,800 - - Stock Option (Right to Buy)
Lawrence Corey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 51,800 51,800 - - Stock Option (Right to Buy)
Vassiliki Economides See Remarks Purchase of securities on an exchange or from another person at price $ 1.90 per share. 23 May 2023 12,000 214,058 (0%) 0% 1.9 22,829 Common Stock
Andrew R. Allen Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 738,550 856,750 (2%) 2% 0 Common Stock
Erin Jones See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 252,845 305,914 (0%) 0% 0 Common Stock
Matthew Hawryluk See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 191,771 248,311 (0%) 0% 0 Common Stock
Karin Jooss See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 252,763 630,147 (1%) 0% 0 Common Stock
Vassiliki Economides See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 179,058 202,058 (0%) 0% 0 Common Stock
James Cho Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 64,515 111,407 (0%) 0% 0 Common Stock
Lawrence Corey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2022 38,000 38,000 - - Stock Option (Right to Buy)
Richard A. Heyman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 19,000 19,000 - - Stock Option (Right to Buy)
Steve E. Krognes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 19,000 19,000 - - Stock Option (Right to Buy)
Naiyer Rizvi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 19,000 19,000 - - Stock Option (Right to Buy)
Shefali Agarwal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 19,000 19,000 - - Stock Option (Right to Buy)
Clare Fisher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 8,693 8,693 - - Stock Option (Right to Buy)
Andrew R. Allen Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 410,000 410,000 - - Stock Option (Right to Buy)
Andrew R. Allen Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 70,000 118,200 (0%) 0% 0 Common Stock
Erin Jones Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 163,013 163,013 - - Stock Option (Right to Buy)
Erin Jones Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 27,169 53,069 (0%) 0% 0 Common Stock
Matthew Hawryluk See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 21,612 53,351 (0%) 0% 0 Common Stock
Matthew Hawryluk See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 129,675 129,675 - - Stock Option (Right to Buy)
Karin Jooss See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 27,600 377,384 (1%) 0% 0 Common Stock
Karin Jooss See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 165,600 165,600 - - Stock Option (Right to Buy)
Vassiliki Economides EVP & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 138,000 138,000 - - Stock Option (Right to Buy)
Vassiliki Economides EVP & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 23,000 23,000 (0%) 0% 0 Common Stock
Rahsaan Thompson EVP and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 115,440 115,440 - - Stock Option (Right to Buy)
Rahsaan Thompson EVP and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 19,240 58,698 (0%) 0% 0 Common Stock
James Cho Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 4,400 43,505 (0%) 0% 0 Common Stock
James Cho Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 26,300 26,300 - - Stock Option (Right to Buy)
Clare Fisher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2022 38,000 38,000 - - Stock Option (Right to Buy)
Erin Jones See Remarks Sale of securities on an exchange or to another person at price $ 11.14 per share. 01 Nov 2021 1,000 20,000 (0%) 0% 11.1 11,140 Common Stock
Erin Jones See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Nov 2021 1,000 32,971 - - Stock Option (Right to Buy)
Erin Jones See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. 01 Nov 2021 1,000 21,000 (0%) 0% 0.3 345 Common Stock
Erin Jones See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2021 1,000 33,971 - - Stock Option (Right to Buy)
Erin Jones See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2021 1,000 34,971 - - Stock Option (Right to Buy)
Erin Jones See Remarks Sale of securities on an exchange or to another person at price $ 10.71 per share. 01 Oct 2021 1,000 20,000 (0%) 0% 10.7 10,710 Common Stock
Erin Jones See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. 01 Oct 2021 1,000 21,000 (0%) 0% 0.3 345 Common Stock
Erin Jones See Remarks Sale of securities on an exchange or to another person at price $ 10.68 per share. 01 Oct 2021 1,000 20,000 (0%) 0% 10.7 10,680 Common Stock
Erin Jones See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. 01 Oct 2021 1,000 21,000 (0%) 0% 0.3 345 Common Stock
Erin Jones See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. 08 Sep 2021 2,000 47,900 (0%) 0% 0.3 690 Common Stock
Erin Jones See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Sep 2021 2,000 35,971 - - Stock Option (Right to Buy)
Erin Jones See Remarks Sale of securities on an exchange or to another person at price $ 11.37 per share. 08 Sep 2021 2,000 45,900 (0%) 0% 11.4 22,748 Common Stock
Thomas Woiwode Director Other type of transaction at price $ 0.00 per share. 25 Aug 2021 6,668 0 (0%) 0% 0 Common Stock
Thomas Woiwode Director Other type of transaction at price $ 0.00 per share. 25 Aug 2021 128 128 (0%) 0% 0 Common Stock
Thomas Woiwode Director Other type of transaction at price $ 0.00 per share. 25 Aug 2021 6,612 0 (0%) 0% 0 Common Stock
Thomas Woiwode Director Other type of transaction at price $ 0.00 per share. 25 Aug 2021 6,612 6,612 (0%) 0% 0 Common Stock
Thomas Woiwode Director Other type of transaction at price $ 0.00 per share. 25 Aug 2021 444,744 902,965 (2%) 1% 0 Common Stock
Thomas Woiwode Director Other type of transaction at price $ 0.00 per share. 25 Aug 2021 6,668 6,668 (0%) 0% 0 Common Stock
Vassiliki Economides EVP & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 215,000 215,000 - - Stock Option (Right to Buy)
Richard A. Heyman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2021 19,000 19,000 - - Stock Option (Right to Buy)
Steve E. Krognes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2021 19,000 19,000 - - Stock Option (Right to Buy)
Naiyer Rizvi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2021 937 937 - - Stock Option (Right to Buy)
Shefali Agarwal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2021 937 937 - - Stock Option (Right to Buy)
Judith J. Li Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2021 19,000 19,000 - - Stock Option (Right to Buy)
Naiyer Rizvi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2021 38,000 38,000 - - Stock Option (Right to Buy)
Shefali Agarwal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2021 38,000 38,000 - - Stock Option (Right to Buy)
Raphael Rousseau See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.76 per share. 27 May 2021 2,900 2,900 (0%) 0% 0.8 2,201 Common Stock
Raphael Rousseau See Remarks Sale of securities on an exchange or to another person at price $ 9.00 per share. 27 May 2021 2,900 0 (0%) 0% 9.0 26,112 Common Stock
Raphael Rousseau See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 May 2021 2,900 122,426 - - Stock Option (Right to Buy)
Andrew R. Allen Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2021 290,000 290,000 - - Stock Option (Right to Buy)
Erin Jones See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2021 100,000 100,000 - - Stock Option (Right to Buy)
Matthew Hawryluk See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2021 60,000 60,000 - - Stock Option (Right to Buy)
Karin Jooss See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2021 100,000 100,000 - - Stock Option (Right to Buy)
Raphael Rousseau See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2021 80,000 80,000 - - Stock Option (Right to Buy)
Roman Yelensky See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.76 per share. 08 Mar 2021 50,724 183,948 (0%) 0% 0.8 38,500 Common Stock
Roman Yelensky See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Mar 2021 50,724 0 - - Stock Option (Right to Buy)
Roman Yelensky See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2021 60,000 60,000 - - Stock Option (Right to Buy)
Vijay Yabannavar See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2021 60,000 60,000 - - Stock Option (Right to Buy)
Rahsaan Thompson See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2021 60,000 60,000 - - Stock Option (Right to Buy)
James Cho Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2021 25,000 25,000 - - Stock Option (Right to Buy)
Raphael Rousseau See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jan 2021 10,000 125,326 - - Stock Option (Right to Buy)
Raphael Rousseau See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.76 per share. 19 Jan 2021 10,000 10,000 (0%) 0% 0.8 7,600 Common Stock
Raphael Rousseau See Remarks Sale of securities on an exchange or to another person at price $ 25.07 per share. 19 Jan 2021 10,000 0 (0%) 0% 25.1 250,705 Common Stock
Raphael Rousseau See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jan 2021 20,000 135,326 - - Stock Option (Right to Buy)
Raphael Rousseau See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.76 per share. 19 Jan 2021 20,000 20,000 (0%) 0% 0.8 15,200 Common Stock
Raphael Rousseau See Remarks Sale of securities on an exchange or to another person at price $ 17.53 per share. 19 Jan 2021 20,000 0 (0%) 0% 17.5 350,564 Common Stock
Roman Yelensky See Remarks Sale of securities on an exchange or to another person at price $ 22.10 per share. 19 Jan 2021 10,000 160,624 (0%) 0% 22.1 221,029 Common Stock
Andrew R. Allen Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 48,200 48,200 (0%) 0% 0 Common Stock
Matthew Hawryluk See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 19,600 24,198 (0%) 0% 0 Common Stock
Karin Jooss See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 27,900 349,784 (0%) 0% 0 Common Stock
Raphael Rousseau See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 29,700 29,700 (0%) 0% 0 Common Stock
Roman Yelensky See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 27,400 170,624 (0%) 0% 0 Common Stock
Vijay Yabannavar See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 28,000 31,696 (0%) 0% 0 Common Stock
Rahsaan Thompson EVP and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 25,500 29,487 (0%) 0% 0 Common Stock
Erin Jones See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Aug 2020 10,000 37,971 - - Stock Option (Right to Buy)
Erin Jones See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. 17 Aug 2020 10,000 20,000 (0%) 0% 0.3 3,450 Common Stock
Nicholas J. Simon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 12,500 12,500 - - Stock Option (Right to Buy)
Richard A. Heyman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 12,500 12,500 - - Stock Option (Right to Buy)
Thomas Woiwode Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 12,500 12,500 - - Stock Option (Right to Buy)
Steve E. Krognes None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 12,500 12,500 - - Stock Option (Right to Buy)
Judith Li None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 12,500 12,500 - - Stock Option (Right to Buy)
Rahsaan Thompson EVP and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2020 85,000 85,000 - - Stock Option (Right to Buy)
Andrew R. Allen Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2020 275,000 275,000 - - Stock Option (Right to Buy)
Erin Jones See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2020 140,000 140,000 - - Stock Option (Right to Buy)
Jean-Marc Bellemin See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2020 110,000 110,000 - - Stock Option (Right to Buy)
Matthew Hawryluk See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2020 50,000 50,000 - - Stock Option (Right to Buy)
Karin Jooss See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2020 110,000 110,000 - - Stock Option (Right to Buy)
Raphael Rousseau See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2020 110,000 110,000 - - Stock Option (Right to Buy)
Roman Yelensky See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2020 130,000 130,000 - - Stock Option (Right to Buy)
Vijay Yabannavar See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2020 110,000 110,000 - - Stock Option (Right to Buy)
Raphael Rousseau See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Aug 2019 10,000 155,326 - - Stock Option (Right to Buy)
Raphael Rousseau See Remarks Sale of securities on an exchange or to another person at price $ 10.76 per share. 21 Aug 2019 10,000 0 (0%) 0% 10.8 107,631 Common Stock
Raphael Rousseau See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.76 per share. 21 Aug 2019 10,000 10,000 (0%) 0% 0.8 7,600 Common Stock
Vijay Yabannavar See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jul 2019 100,000 100,000 - - Stock Option (Right to Buy)
Nicholas J. Simon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2019 8,570 8,570 - - Stock Option (Right to Buy)
Peter Svennilson Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2019 8,570 8,570 - - Stock Option (Right to Buy)
Richard A. Heyman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2019 8,570 8,570 - - Stock Option (Right to Buy)
Thomas Woiwode Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2019 8,570 8,570 - - Stock Option (Right to Buy)
Steve E. Krognes None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2019 8,570 8,570 - - Stock Option (Right to Buy)
Judith Li None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2019 8,570 8,570 - - Stock Option (Right to Buy)
Andrew R. Allen Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2019 180,000 180,000 - - Stock Option (Right to Buy)
Erin Jones See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2019 66,000 66,000 - - Stock Option (Right to Buy)
Jean-Marc Bellemin See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2019 66,000 66,000 - - Stock Option (Right to Buy)
Matthew Hawryluk See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2019 55,000 55,000 - - Stock Option (Right to Buy)
Karin Jooss See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2019 66,000 66,000 - - Stock Option (Right to Buy)
Raphael Rousseau See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2019 66,000 66,000 - - Stock Option (Right to Buy)
Roman Yelensky See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2019 66,000 66,000 - - Stock Option (Right to Buy)
Erin Jones See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2019 10,000 47,971 - - Stock Option (Right to Buy)
Erin Jones See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. 29 Jan 2019 10,000 10,000 (0%) 0% 0.3 3,450 Common Stock
Peter Svennilson Director, Ten Percent Owner 02 Oct 2018 3,102,934 3,102,934 (124%) 124% 0 Common Stock
Peter Svennilson Director, Ten Percent Owner 02 Oct 2018 929,022 0 - - Series B Convertible Preferred Stock
Peter Svennilson Director, Ten Percent Owner 02 Oct 2018 2,173,912 0 - - Series A Convertible Preferred Stock
Thomas Woiwode Director, Ten Percent Owner 02 Oct 2018 929,020 0 - - Series B Convertible Preferred Stock
Thomas Woiwode Director, Ten Percent Owner 02 Oct 2018 3,102,929 3,102,929 (124%) 124% 0 Common Stock
Thomas Woiwode Director, Ten Percent Owner 02 Oct 2018 2,173,909 0 - - Series A Convertible Preferred Stock
Nicholas J. Simon Director, Ten Percent Owner 28 Sep 2018 668,896 0 - - Series B Convertible Preferred Stock
Nicholas J. Simon Director, Ten Percent Owner 28 Sep 2018 2,234,112 2,567,445 (103%) 89% 0 Common Stock
Nicholas J. Simon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 15.00 per share. 28 Sep 2018 333,333 333,333 (1%) 1% 15 4,999,995 Common Stock
Nicholas J. Simon Director, Ten Percent Owner 28 Sep 2018 1,565,216 0 - - Series A Convertible Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters